Mind Medicine (MindMed) Inc. (NEO: MMED)(OTCQB: MMEDF)announced that it is working with the University Hospital Basel’s Liechti Lab on a combination MDMA and LSD in Phase 1 clinical trial. The Phase 1 MDMA-LSD trial is scheduled to start in Q4 of this year in Basel, Switzerland. “A new treatment paradigm combining MDMA and LSD may … Continue reading MindMed Plans MDMA-LSD Trial To Study ‘Bad Trip’ Reduction